Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Mutation Research|December 4, 2003
Signaling events for metallothionein inductionFarzana Haq, Meghan Mahoney, James Koropatnick
Journal of Toxicology and Environmental Health. Part A|April 25, 2007
Mouse monocytes (RAW CELLS) and the handling of cysteine and homocysteine S-conjugates of inorganic mercury and methylmercuryRudolfs K Zalups, James Koropatnick, Lucy Joshee
Journal of Inorganic Biochemistry|January 23, 2002
Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiproneJason D Czachor, M George Cherian, James Koropatnick
Cancer Letters|January 2, 2007
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cellsKaren L Morley, Peter J Ferguson, James Koropatnick
American Journal of Physiology. Endocrinology and Metabolism|July 25, 2013
Metallothionein-I- and -II-deficient mice display increased susceptibility to cadmium-induced fetal growth restrictionJohanna Selvaratnam, Haiyan Guan, James Koropatnick, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2017
Synergistic Antiproliferative Activity of the RAD51 Inhibitor IBR2 with Inhibitors of Receptor Tyrosine Kinases and Microtubule ProteinPeter J Ferguson, Mark D Vincent, James Koropatnick
Frontiers in Immunology|March 15, 2024
CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homograftsFaizah M Alotaibi, Wei-Ping Min, James Koropatnick
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2007
Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell linesAleksandra A Pandyra, Randal Berg, Mark Vincent, et al.
Tumori|October 3, 2015
Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalanPeter J Ferguson, Alexander Sykelyk, Rene Figueredo, et al.
Frontiers in Immunology|February 15, 2021
Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector FunctionFaizah Alotaibi, Mark Vincent, Wei-Ping Min, et al.
Pageof 7